- Home
- OKTA vs ZBH Comparison
OKTA vs ZBH Comparison
Compare OKTA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKTA
- ZBH
- Stock Information
- Founded
- OKTA 2009
- ZBH 1927
- Country
- OKTA United States
- ZBH United States
- Employees
- OKTA N/A
- ZBH N/A
- Industry
- OKTA Computer Software: Prepackaged Software
- ZBH Industrial Specialties
- Sector
- OKTA Technology
- ZBH Health Care
- Exchange
- OKTA Nasdaq
- ZBH Nasdaq
- Market Cap
- OKTA 15.8B
- ZBH 19.9B
- IPO Year
- OKTA 2017
- ZBH N/A
- Fundamental
- Price
- OKTA $80.69
- ZBH $89.08
- Analyst Decision
- OKTA Buy
- ZBH Buy
- Analyst Count
- OKTA 39
- ZBH 19
- Target Price
- OKTA $122.41
- ZBH $108.56
- AVG Volume (30 Days)
- OKTA 1.7M
- ZBH 2.3M
- Earning Date
- OKTA 12-02-2025
- ZBH 11-05-2025
- Dividend Yield
- OKTA N/A
- ZBH 1.08%
- EPS Growth
- OKTA N/A
- ZBH N/A
- EPS
- OKTA 0.84
- ZBH 4.03
- Revenue
- OKTA $2,763,000,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- OKTA $12.72
- ZBH $8.20
- Revenue Next Year
- OKTA $9.38
- ZBH $5.92
- P/E Ratio
- OKTA $96.93
- ZBH $21.98
- Revenue Growth
- OKTA 12.68
- ZBH 5.47
- 52 Week Low
- OKTA $71.84
- ZBH $85.33
- 52 Week High
- OKTA $127.57
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- OKTA 30.42
- ZBH 34.94
- Support Level
- OKTA $83.06
- ZBH $86.51
- Resistance Level
- OKTA $86.87
- ZBH $91.28
- Average True Range (ATR)
- OKTA 2.56
- ZBH 2.89
- MACD
- OKTA -0.53
- ZBH -0.69
- Stochastic Oscillator
- OKTA 3.87
- ZBH 21.24
About OKTA Okta Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.